CIK medium
A culture medium and basal medium technology, applied in the direction of cell culture active agent, culture process, tissue culture, etc., can solve the problems of unsatisfactory number of CIK cells, poor activity and proliferation ability of CIK cells, etc., to improve activity and proliferation ability , Avoid reducing the concentration too fast, and enhance the effect of cross-linking
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0032] The present embodiment provides a kind of CIK cell culture medium, and described CIK cell culture medium comprises DMEM medium and the additive that is added in DMEM medium, by final concentration, described additive comprises the component of following content: polylysine acid 25μg / mL, BCG polysaccharide nucleic acid 10mg / mL, sodium selenite 0.035μmol / mL, 4-hydroxyethylpiperazineethanesulfonic acid 6μg / mL, reduced glutathione 3μg / L, adenosine Ammoniase 9µg / mL, IFN-γ sustained-release microspheres 2.5mg / mL, IL-2 sustained-release microspheres 1.75mg / mL, autologous plasma 5mL / L.
[0033] Preferably, the preparation method of the IL-2 sustained-release microspheres comprises the following steps:
[0034] A, adding IL-2 and polyethylene glycol to the aqueous solution that has been added with mannitol and zinc sulfate in advance, after stirring evenly, a mixture A is obtained, the concentration of IL-2 in the mixture A is 2wt%, and the concentration of polyethylene glycol ...
Embodiment 2
[0055] The present embodiment provides a kind of CIK cell culture medium, and described CIK cell culture medium comprises basal medium and the additive that is added in the basal medium, and in terms of final concentration, described additive comprises the component of following content: Polylysine acid 20μg / mL, BCG polysaccharide nucleic acid 15mg / mL, sodium selenite 0.03μmol / mL, 4-hydroxyethylpiperazineethanesulfonic acid 8μg / mL, reduced glutathione 2μg / L, adenosine Ammoniase 12µg / mL, IFN-γ sustained-release microspheres 2mg / mL, IL-2 sustained-release microspheres 2mg / mL, autologous plasma 4mL / L.
[0056] Preferably, the preparation method of the IL-2 sustained-release microspheres comprises the following steps:
[0057] A. Add IL-2 and polyethylene glycol to the aqueous solution pre-added with mannitol and zinc sulfate, and stir evenly to obtain mixture A. The concentration of IL-2 in the mixture A is 1.2wt%, polyethylene glycol The concentration is 12 wt%;
[0058] B. Ad...
Embodiment 3
[0079] The present embodiment provides a kind of CIK cell culture medium, and described CIK cell culture medium comprises DMEM medium and the additive that is added in the basal medium, by final concentration, described additive comprises the component of following content: polylysine Acid 30μg / mL, BCG polysaccharide nucleic acid 5mg / mL, sodium selenite 0.04μmol / mL, 4-hydroxyethylpiperazineethanesulfonic acid 5μg / mL, reduced glutathione 4μg / L, adenosine Ammoniase 8µg / mL, IFN-γ sustained-release microspheres 3mg / mL, IL-2 sustained-release microspheres 1.5mg / mL, autologous plasma 6mL / L.
[0080] Preferably, the preparation method of the IL-2 sustained-release microspheres comprises the following steps:
[0081] A. Add IL-2 and polyethylene glycol to the aqueous solution pre-added with mannitol and zinc sulfate, and stir evenly to obtain mixture A. The concentration of IL-2 in the mixture A is 2.5wt%, polyethylene glycol The concentration is 7wt%;
[0082] B. Add polyglycolic a...
PUM
Property | Measurement | Unit |
---|---|---|
Particle size | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com